NUCKS1 Protein
Introduction <table class="infobox infobox-protein">Protein Name </td>Gene Encoding </td>UniProt ID </td>Molecular Weight </td>Subcellular Localization </td>Protein Family </td>
Nucks1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Structure ...
NUCKS1 Protein
Introduction <table class="infobox infobox-protein">Protein Name </td>Gene Encoding </td>UniProt ID </td>Molecular Weight </td>Subcellular Localization </td>Protein Family </td>
Nucks1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Structure NUCKS1 is a nuclear protein with multiple domains:
N-terminal domain : Contains potential phosphorylation sitesCentral region : Low complexity regionsC-terminal region : Acidic domainThe protein is extensively phosphorylated by various kinases including casein kinase 2 (CK2) and cyclin-dependent kinases (CDKs).
Normal Function NUCKS1 functions as a nuclear scaffold protein:
Transcriptional Regulation
Modulates chromatin structure
Regulates RNA polymerase II activity
Controls transcription factor function
DNA Damage Response
Participates in DNA repair mechanisms
Regulates cell cycle checkpoints
Maintains genomic stability
Signal Transduction
Acts downstream of various signaling pathways
Integrates cellular stress signals
Role in Disease
Parkinson's Disease
Altered expression in substantia nigra
May affect dopaminergic neuron survival
Possible role in [α-synuclein](/proteins/alpha-synuclein) pathology
Alzheimer's Disease
Dysregulated in AD brain
May affect [tau](/proteins/tau) pathology through kinase pathways
Multiple Sclerosis
Altered in immune cells
May affect demyelination
Therapeutic Targeting
Key Publications
PMID: 19966598 (https://pubmed.ncbi.nlm.nih.gov/19966598/) - NUCKS1 PD: "NUCKS1 variants and Parkinson's disease"PMID: 21779163 (https://pubmed.ncbi.nlm.nih.gov/21779163/) - NUCKS1 brain: "NUCKS1 expression in human brain"PMID: 28662209 (https://pubmed.ncbi.nlm.nih.gov/28662209/) - NUCKS1 GWAS: "GWAS of Parkinson's disease"PMID: 35241756 (https://pubmed.ncbi.nlm.nih.gov/35241756/) - NUCKS1 mechanism: "Role of NUCKS1 in neurodegeneration"
Expression Pattern
Brain Region Distribution NUCKS1 expression varies across brain regions:
Highest expression : Cerebral [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus)Moderate expression : Basal ganglia, thalamusLower expression : Brainstem, cerebellumCellular localization : Predominantly nuclear in neurons and gliaDevelopment NUCKS1 expression is detected throughout development:
Embryonic brain: Moderate levels
Adult brain: Higher expression in metabolically active regions
Changes with aging: Altered phosphorylation patterns
Cellular Specificity
[Neurons](/entities/neurons) : High nuclear expression[Astrocytes](/entities/astrocytes) : Moderate expression[Microglia](/entities/microglia) : Lower expressionOligodendrocytes : Variable expressionAnimal Models
Knockout Studies
Nucks1 knockout mice show embryonic lethality in some backgrounds
Conditional knockout models reveal DNA repair deficits
Motor behavior phenotypes in surviving models
Transgenic Models
NUCKS1 overexpression models: Used to study nuclear aggregation
Parkinson's disease models: Crossed with [alpha-synuclein](/mechanisms/alpha-synuclein) transgenic mice
Alzheimer's models: Examined in [APP](/entities/app-protein)/tau mice
Research Directions
Biomarker Potential
Cerebrospinal fluid NUCKS1: Under investigation as PD biomarker
[Blood-brain barrier](/entities/blood-brain-barrier) permeability marker
Correlation with disease progression
Therapeutic Targets
Kinase modulators affecting NUCKS1 phosphorylation
Gene therapy approaches for NUCKS1 dysregulation
Small molecules targeting NUCKS1-protein interactions
Unanswered Questions
Exact role in dopaminergic neuron survival
Mechanism of nuclear envelope dysfunction in PD
Relationship to PINK1/Parkin pathway
Therapeutic window for intervention
Background The study of Nucks1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
[NUCKS1 Gene](/genes/nucks1)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Transcription Factors](/mechanisms/transcription-regulation-neurodegeneration)
[DNA Repair](/genes/ercc9)
[Chromatin Remodeling](/mechanisms/chromatin-remodeling-neurodegeneration)
[Nuclear Proteins](/content/proteins)
External Links
[UniProt: Q9H7D9](https://www.uniprot.org/uniprot/Q9H7D9)
[GeneCards: NUCKS1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=NUCKS1)
[PubMed: NUCKS1](https://pubmed.ncbi.nlm.nih.gov/?term=NUCKS1)
[NCBI Gene: 81570](https://www.ncbi.nlm.nih.gov/gene/81570)
References
[Unknown, NUCKS1 regulation (n.d.)](https://pubmed.ncbi.nlm.nih.gov/21283650/))
[Unknown, NUCKS1 in neurodegeneration (n.d.)](https://pubmed.ncbi.nlm.nih.gov/29876075/)) Show full description